Lead Product(s): Mitochondria therapy
Therapeutic Area: Neurology Product Name: Undisclosed
Highest Development Status: Discovery Product Type: Cell and Gene therapy
Partner/Sponsor/Collaborator: Axil Capital Partners
Deal Size: $9.8 million Upfront Cash: Undisclosed
Deal Type: Series A Financing September 01, 2020
LUCA Science is developing an innovative platform of highly functional mitochondrial using proprietary technologies. LUCA Science’s mitochondria can be stored and delivered as a biopharmaceutical agent.